Fol. Biol. 2012, 58, 81-86
https://doi.org/10.14712/fb2012058020081
PAR2 Knock-Out C57Bl6 Mice as a Model for Evaluating Metastases of Cancer Cells: Pilot in Vivo Study of the Metastatic Potential of B16 Melanoma in Knock-Out (PAR2-/-) Animals
References
1. , M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 130, 248-282.
<https://doi.org/10.1016/j.pharmthera.2011.01.003>
2. , B., Hewett, P. W., Cudmore, M. J., Fujisawa, T., Saifeddine, M., Williams, H., Ramma, W., Sissaoui, S., Jayaraman, P. S., Ohba, M., Ahmad, S., Hollenberg, M. D., Ahmed, A. (2010) Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension 55, 689-697.
<https://doi.org/10.1161/HYPERTENSIONAHA.109.136333>
3. , D. K., Ploug, K. B., Ramachandran, R., Olesen, J., Gupta, S. (2010) Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery. Headache 50, 1017-1030.
<https://doi.org/10.1111/j.1526-4610.2010.01679.x>
4. , O., Thoma, M. S., Wong, H., Grady, E. F., Bunnett, N. W. (1999) Trafficking of proteinase-activated receptor-2 and β-arrestin-1 tagged with green fluorescent protein. β-Arrestin-dependent endocytosis of a proteinase receptor. J. Biol. Chem. 274, 18524-18535.
<https://doi.org/10.1074/jbc.274.26.18524>
5. , A. P., Petersen, I. (2010) Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer. J. Mol. Histol. 41, 89-99.
<https://doi.org/10.1007/s10735-010-9274-6>
6. , R. C., Schoenecker, J. G., Hart, J. P., Hoffman, M. R., Pizzo, S. V., Lawson, J. H. (2003) Protease-activated receptor-2 signaling triggers dendritic cell development. Am. J. Pathol. 162, 1817-1822.
<https://doi.org/10.1016/S0002-9440(10)64316-7>
7. , K. K., Oikonomopoulou, K., Baruch, A., Ramachandran, R., Beck, P., Diamandis, E. P., Hollenberg, M. D. (2008) Proteinases as hormones: targets and mechanisms for proteolytic signaling. Biol. Chem. 389, 971-982.
<https://doi.org/10.1515/BC.2008.120>
8. , B., Grage-Griebenow, E., Csernok, E., Butherus, K., Ehlers, S., Gross, W. L., Holle, J. U. (2010) The role of proteinase 3 (PR3) and the protease-activated receptor-2 (PAR-2) pathway in dendritic cell (DC) maturation of human-DC-like monocytes and murine DC. Clin. Exp. Rheumatol. 28 (Suppl 57), 56-61.
9. , A., Kuroda, R., Minami, T., Kataoka, K., Taneda, M. (1998) Increased vascular permeability by a specific agonist of protease-activated receptor-2 in rat hindpaw. Br. J. Pharmacol. 125, 419-422.
<https://doi.org/10.1038/sj.bjp.0702063>
10. , N., Würdinger, R., Zippel, A., Aumüller, G., Wennemuth, G. (2010) Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia. Prostate 70, 1350-1358.
<https://doi.org/10.1002/pros.21170>
11. , R., Mandáková, P., Netíková, I., Poucková, P., Olejár, T. (2007) Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231. Physiol. Res. 56, 475-484.
<https://doi.org/10.33549/physiolres.930959>
12. , T. A., Pawlinski, R., Richards, K. L., Church, F. C., Mackman, N. (2010) Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood 116, 5037-5044.
<https://doi.org/10.1182/blood-2010-06-293126>
13. , S., Tajima, H., Okamoto, K., Hayashi, H., Nakagawara, H., Onishi, I., Takamura, H., Kitagawa, H., Fushida, S., Tani, T., Fujimura, T., Kayahara, M., Ohta, T., Wakayama, T., Iseki, S., Harada, S. (2010) Tumour-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2. Int. J. Oncol. 36, 793-800.
<https://doi.org/10.3892/ijo_00000555>
14. , G., Fuertes, S., Narayan, S., Busso, N., Acha-Orbea, H., So, A. (2010) Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo. Immunology 129, 20-27.
<https://doi.org/10.1111/j.1365-2567.2009.03144.x>
15. , U. J., Dores, M. R., Chen, B., Trejo, J. (2010) Signal transduction by protease-activated receptors. Br. J. Pharmacol. 160, 191-203.
<https://doi.org/10.1111/j.1476-5381.2010.00705.x>
16. , J.Y., Gardiner, B., Grimmond, S., Fairlie, D. P. (2010) Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells. PLoS One 5, e13809
<https://doi.org/10.1371/journal.pone.0013809>
17. , M., Olejár, T., Sebková, V., Zadinová, M., Boubelík, M., Poucková, P. (2001) Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother. Pharmacol. 47 (Suppl), S16-22.
<https://doi.org/10.1007/s002800170004>
18. , X., Liu, H. T., Li, S., Li, K., Lin, N., Fan, Q. X., Zheng, Y. L. (2010) Prognostic value of protease-activated receptor 2 expression in oesophageal squamous cell carcinoma. J. Int. Med. Res. 38, 1381-1388.
<https://doi.org/10.1177/147323001003800420>
19. , X. P., Li, Y., Wang, Y., Wang, Y., Wang, P. (2010) β-Tryptase up-regulates vascular endothelial growth factor expression via proteinase-activated receptor-2 and mitogen-activated protein kinase pathways in bone marrow stromal cells in acute myeloid leukemia. Leuk. Lymphoma 51, 1550-1558.
<https://doi.org/10.3109/10428194.2010.496013>
20. , N., Takagi, T., Isozaki, Y., Suzuki, T., Ichikawa, H., Yoshikawa, T. (2011) Proinflammatory role of proteaseactivated receptor-2 in intestinal ischemia/reperfusion injury in rats. Mol. Med. Report. 4, 81-86.
21. , X., Wang, W., True, L. D., Vessella, R. L., Takayama, T. K. (2009) Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis. Prostate 69, 727-736.
<https://doi.org/10.1002/pros.20920>
